Get started
Author

Takehiro Akahane

Observed names: Akahane Takehiro, Akahane, Takehiro, T AKAHANE, T Akahane, T. Akahane, TAKEHIRO AKAHANE
ORCID: 0000-0001-8667-2120
Observed ORCID: 0000-0001-8667-2120
OpenAlex ID: A5020294749
Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration.
1997 · T Akahane, T Iwasaki, et al. · PubMed · 144
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group
2018 · Toshie Mashiba, Kouji Joko, et al. · PLoS ONE · 58
PDF
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
2021 · Kaoru Tsuchiya, Masayuki Kurosaki, et al. · Cancers · 54
PDF
The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study
2019 · Masanori Atsukawa, Akihito Tsubota, et al. · Alimentary Pharmacology & Therapeutics · 52
Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma
2022 · Hironori Ochi, Masayuki Kurosaki, et al. · Hepatology Research · 49
PDF
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus
2020 · Nobuharu Tamaki, Masayuki Kurosaki, et al. · Clinical Infectious Diseases · 45
PDF
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group
2018 · Keiji Tsuji, Masayuki Kurosaki, et al. · Journal of Gastroenterology · 45
The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
2020 · the KTK49 Liver Study Group, Akito Nozaki, et al. · Hepatology International · 35
Safety and factors contributing to the difficulty of laparoscopic surgery for rectal cancer treated with preoperative chemoradiotherapy
2013 · S. Ishihara, T. Watanabe, et al. · Techniques in Coloproctology · 34
Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group
2018 · Takehiro Akahane, Masayuki Kurosaki, et al. · Hepatology Research · 33
1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial
2013 · Yasuteru Kondo, Takanobu Kato, et al. · PLoS ONE · 33
PDF
Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection
2019 · Hidenori Toyoda, Masanori Atsukawa, et al. · Journal of Gastroenterology and Hepatology · 32
Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group
2021 · Toshifumi Tada, Masayuki Kurosaki, et al. · Journal of Medical Virology · 30
Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan
2019 · Hidenori Toyoda, Masanori Atsukawa, et al. · Open Forum Infectious Diseases · 30
PDF
Hepatocellular carcinomas supplied by inferior phrenic arteries
1998 · N. Tanabe, T. Iwasaki, et al. · Acta Radiologica · 29
Comparison of hepatitis B virus genotypes B and C among chronically hepatitis B virus‐infected patients who received nucleos(t)ide analogs: A multicenter retrospective study
2019 · Jun Inoue, Takehiro Akahane, et al. · Hepatology Research · 28
Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group
2019 · Toshie Mashiba, Kouji Joko, et al. · Hepatology Research · 24
PDF
Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan
2009 · Jun Inoue, Yoshiyuki Ueno, et al. · Journal of Gastroenterology · 24
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
2020 · Masanori Atsukawa, Akihito Tsubota, et al. · Infectious Diseases and Therapy · 23
PDF
Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan
2008 · Takayuki Kogure, Yoshiyuki Ueno, et al. · World Journal of Gastroenterology · 23
PDF
Stromal expression of urokinase‐type plasminogen activator receptor (uPAR) is associated with invasive growth in primary liver cancer
1998 · Takehiro Akahane, Motoyasu Ishii, et al. · Liver International · 22
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group
2023 · Shintaro Takaki, Masayuki Kurosaki, et al. · Investigational New Drugs · 21
Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis
2021 · Masanori Atsukawa, Akihito Tsubota, et al. · Hepatology Research · 20
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score
2020 · Shun Kaneko, Masayuki Kurosaki, et al. · Scientific Reports · 20
PDF
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus
2021 · Nobuharu Tamaki, Masayuki Kurosaki, et al. · Hepatology Communications · 19
PDF
Works count: 80
Citation count: 1,193
H-index: 21
I10-index: 33
Year
Topic
Type